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ABSTRACT
The effects of degradation of ranitidine hydrochloride exposed to UVB radiation (l = 310 nm) and oxygen in a weathering
chamber were studied by Fourier Transform Infrared spectroscopy (FTIR) and Attenuated Total Reflectance Fourier Transform
Infrared spectroscopy (ATR-FTIR). ATR-FTIR profile indicated that the degradation was spatially heterogeneous. Significant
amounts of photoproducts were detected only in a directly irradiated layer. Major damage/change was reflected in the appearance
of broad, extended group of signals near the wavenumber 3600-3200 cm-1 or/and 3500-3400 cm-1. We examined whether FTIR-ATR
technique is a great tool to observe the simplest and the first changes on the surface of a substance in powder.
Key words: photodegradation, Fourier Transform Infrared Spectroscopy, ATR, ranitidine hydrochloride

INTRODUCTION
Stability of a drug preparation has to be analysed
under practical use conditions (1). Therefore, commercially available forms (tablets, capsules, and suspension etc.) are examined inside and outside packages.
Very often the samples are tested during long time and/
or under drastic conditions. Sometimes quick information about quality is needed especially in a solid-state
substance. Accelerated testing is widely used for the
prediction of storage stability and quality, estimation
of shelf-lives, and safe storage temperatures of labile
products (2). In the food, pharmaceutical and biotechnology industries, products are stressed by testing at high
temperatures. The results are then extrapolated to normal
storage conditions. Therefore, FDA and other regulatory
agencies require such methods to be well designed (3).
Screening chemical change of a drug or substance used
for drug preparation is usually slow, complicated or
expensive method. A conventional way to attain knowledge of chemical substances stability is to identify any
ongoing degradation process by means of spectral (MS,
NMR, IR, etc.), elemental analysis or chromatography
LC, TLC, HPLC(4). Many operations are need before
each analysis. Fourier transform infrared spectroscopy
(FTIR) is a valuable tool for monitoring such processes
in the solid state (5). Unfortunately, it is not a very popular
* Author for correspondence. Tel: +48-58-349-31-52, +48-58-349-31-56;
Fax: +48-58-349-31-52; E-mail: majam@gumed.edu.pl

method in pharmacy. No Pharmacopoeia suggests FTIR
analysis for drug degradation products. Changes generated after damaging exposition onto different factors (e.g.
light, humidity, temperature, and pH) cause transformations with functional groups that show characteristic
fingerprints in the IR spectrum. It is also useful to record
any changes caused directly on the surface of irradiated
compound (or material) on reflection spectra and subsequently on transmission spectra because the spectral path
length and the optical density accordingly are too large.
This is a fast, relatively cheap and well known method.
On the other hand, it has been proven recently that Attenuated total reflectance – Fourier transform infrared spectroscopy (ATR-FTIR) is very practical for fast estimation
of polymer surface changes during environmental degradation(6), for the study of films subjected to a solution
of a drug(7), real-time monitoring crystallization processes (8) as well as synthesis or adsorption(9).
Factors determining the chemical stability of drug
substances include intrinsic factors such as the molecular
structure of the drug itself and environmental factors,
such as temperature, moisture, pH, buffer species,
oxygen, ionic strength, and light. Light is an omnipresent
factor and very difficult to avoid especially during drug
production process. Chemical consequences after drug
exposition on light might be detected after a long time
and subsequent processes causing radical formation,
energy transfer, luminescence and possible generation
of dramatic therapeutical effect (10). Drugs can become

343
Journal of Food and Drug Analysis, Vol. 17, No. 5, 2009

photoreactive just upon administration to a patient.
Sometimes the interaction of sunlight with pharmaceutical agents results in toxic reactants which are transported in the blood system(11). Therefore, the first structural change of drug compound should be recorded as
fast as possible.
Ranitidine hydrochloride is a representative example
of a very unstable drug component (12). Humidity, high
temperature, light and atmospheric gases (oxygen) bring
about the essential structure changes of ranitidine hydrochloride (13-15). The aim of this work was to show the early
changes on the surface of solid state drug substance –
ranitidine hydrochloride, after either irradiation or spectrophotometric tests.
N-[2-[[[5 -[(d i met hyla m i no)met hyl]-2-f u r a nyl]
methyl]thio]ethyl]-N′-methyl-2-nitro-1,1-ethenediamine
is an H 2 receptor antagonist recommended for the treatment of peptic ulcers (16). Its chemical structure (Figure
1-I), amine and nitro groups cause many problems, especially during storage (17). Degradation products or its
impurities are sources of bad odour and dark colour on
the surface of powder compound. The reactive properties
of the substituted 2-nitro-1,1-vinyldiamino entity allow
different hydrolytic behaviours of the ranitidine molecule under acidic and alkaline conditions (18). In solution it undergoes a fast exchange at room temperature,
with pseudo-first order pH-dependent kinetics(19). It has
been proven that ranitidine was also degraded in direct
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photolysis experiments under summertime sunlight at
noon(20). In literature there are no examples of assignation photodegradation process of ranitidine in its solid
state. There were tested pharmaceuticals containing ranitidine hydrochloride (40°C, 75% RH, with and without
light). Stability of those drugs and total percentage
of degradation products were determinated by HPLC
method (21). Ranitidine hydrochloride powder was also
tested in different humidity (70, 85, 96, 100% RH) and
temperature conditions (45, 55, 65°C)(22). Generally,
ranitidine hydrochloride is described by spectroscopic
methods (23). In the FTIR spectrum, the most labile and
changeable regions of wavenumber are those responsible
for the presence of amine groups stretching N–H at 33253050 cm-1, free –NH at 3270-3200 cm-1 and dimethylamino groups give bands at 2820-2780 cm-1 (24).
In our experiment on ranitidine stability we used a
weathering chamber with a xenone lamp as irradiation
source.

MATERIALS AND METHODS
I. General
Ranitidine HCl (polymorphic Form 2) bulk powder
was purchased from POLPHARMA SA Pharmaceutical
Works (Poland). Potassium bromide (anhydrous) was
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Figure 1. Structure of ranitidine hydrochloride (I) and FTIR spectrum (II) with characteristics (III).
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II. Samples for Irradiation Process
Prepared material needed the same area for irradiation and for each technique of recording FTIR spectrum.
Therefore, the accurately weighed ranitidine hydrochloride powder (1 mg plus potassium bromide to 100 mg) was
compressed to discs using hydraulic press machine (Riken
Seiki Co., Ltd. Japan) equipped with flat-faced punches
and cylindrical die (13 mm i.d.) set a compression force at
10 Mpa; obtained discs were used to record transmission
spectra after exposition to light. The pieces of carrier –
matt adhesive tape stripes (100 mm × 20 mm, not tracing,
not transparent or crystal) were thoroughly covered with
10/15 mg of ranitidine hydrochloride on the whole adhesive part of the tape. The obtained materials were used to
record reflection spectra after exposition to light.
III. Tested Parameters
Changes in absorption values (DA) were studied in
the spectral range 4000-900 cm-1 between spectrum of
not irradiated ranitidine and ranitidine irradiated for a
long time.
IV. Irradiation
Sample discs and sample adhesive tapes (containing
ranitidine hydrochloride) were exposed to UVB irradiation in a Suntest CPS+ Atlas chamber (Accelerated
Tabletop Exposure Systems, Germany) equipped with
xenone lamp (1.1 to 1.5 kW) and two filters: special
window glass and Solar ID65, applied together. Exposure behind window glass is accurated for photostability
testing (Indoor Indirect Daylight) of pharmaceutical
products according to ICH guideline (1) “Photostability
Testing of New Drug Substances and Products”. The
illuminance was set at two values of exposure power:
280 and 700 [W/m 2] at time (1, 2, 3, 5, 10, 13 15, 30, and
24, 48, 120 h). The irradiation tests were carried out at
25-45°C (respectively to the values of energies). Relative
humidity was the same during our investigation.
FTIR spectra of the sample discs were obtained in
transmission technique by FTIR-410 Jasco spectrometer
(Jasco Corporation, Japan). The spectral data were transformed by normalized function. ATR-FTIR spectra of
ranitidine hydrochloride put precisely on adhesive tape
and glue were obtained with the horizontal attenuated
total reflectance (HATR) accessory (reflectance technique). The internal reflecting element (IRE) was a ZnSe
crystal. Spectra were collected in the range 4000-650
cm-1 with 32 scans. Acquired spectra were first corrected
for background based on the signal recorded for the same
ATR crystal, but without the adhesive tape with ranitidine hydrochloride.

RESULTS AND DISCUSSION
This paper presents the possibilities of detecting
the very quick photodegradation process in ranitidine
hydrochloride by FTIR and ATR-FTIR techniques. We
compared the non-irradiated spectra and spectra of drug
substance after exposure to light. The most important
goal of this study was to choose a FTIR technique that
is suitable for monitoring changes on the surface of the
substance after contact with ultraviolet irradiation. Our
work might be useful to exploit during storage process
after synthesis. Furthermore, we committed FTIR method
to avoid solution preparation. Destruction of ranitidine
determination is carried out only in the solid state.
Firstly we irradiated discs and tapes with ranitidine
hydrochloride in the lowest power of weathering chamber
280 W/m 2 for 1, 2, 3, 5, 10, 13 and 15 hours. Afterwards,
we prolonged the exposure time to 60 hours and observed
ranitidine FTIR and ATR-FTIR spectra after 30, 45 and
60 hours. Lastly, we destructed ranitidine during 120
hours of irradiation.
FTIR spectra of irradiated drug did not give any
noticeable difference below 30 hours of irradiation with
the exposure power 280 W/m 2 (Figure 2). Discs contained
ranitidine and absorbed irradiation but transmission
spectra was not sensitive enough for such changes in the
whole recorded disc. In a case of tape irradiation, the
initial differences between the spectrum of non-irradiated
and irradiated drug substances were observed very soon,
after 15 hours (Figure 3). The substance in the probes
likely intensified the results on the ATR/FTIR spectra.
Tapes contained ten times more a substance then discs
with KBr. Therefore, effect of a change on the surface of
substance was detectable in a very short time (few hours)
using the reflection technique. The most sensitive region
for absorption changes after irradiation was 3600-2400
cm-1, indicating an increase of absorption values. In
addition, the region near wavenumber of 1800-1000 cm-1
has changed. A new band has risen at 1670 cm-1. Bands
generally maintained their shape and character, but their
peaks were very difficult to identify due to extending
nature of a region near 3600-2400 cm-1.
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Figure 2. Transmission FTIR for ranitidine hydrochloride irradiated
with the exposure power of 280 W/m 2 up to 60 hours.
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(1)

A0 − A1
·100%
A0

(2)

A1 - absorption value for irradiated substance
A0 - absorption value for not irradiated substance
The first consequence from exposing ranitidine to
light was clearly shown on the irradiated layer (surface
of the tape). Two-fold duration of drug photodegradation was needed to create changes on FTIR spectrum comparing with fast answer in ATR spectrum. To
examine the amount of photodegradated drug substance
simply and quickly, it was better to record ATR spectrum, in which increase of absorbance could be attributed
to degradation product.
There were two independent experiments performed
for agent impact assessment in photodegradation of
ranitidine hydrochloride, in terms time and amount of
energy consumed. Firstly all probes were continuously
irradiated for 60 hours in the Atlas chamber 280 W/m 2.
Secondly the probes were irradiated for 24 hours in the
Atlas chamber 700 W/m 2. The same amount of energy of
60 and 48 MJ/m 2 was used. Radiant exposure was irradiance integrated over time. Therefore, the following equation applies:

J
P[W ]
]=
� t[sec] , where E = energy, P = power
2
m
S [m 2 ]
of the weathering chamber, S = area, t = time, J = joule,
W = watt, m = meter.
Recorded spectra (transmission and reflection) indicated no differences in the results. Amount of energy
used was the only factor creating changes in ranitidine
hydrochloride which ultimately led to photodegradation.
Finally we irradiated discs and tapes with ranitidine
hydrochloride in the power of weathering chamber 700
W/m 2 24, 48 for 120 hours to achieve total degradation of
ranitidine. Spectacular changes on spectrum for photodestructed ranitidine are shown in Figures 4 and 5.
Bands were blurred in the range of 3600-2800 cm -1
most of and gradually disappeared in the range of 2700 to
2350 cm-1. A new band arose in 1675 cm-1. Changes were
so huge from the spectrum of non-irradiated substance
that we obtained significantly (in average about 80% obtained from equations 1 and 2) different spectra.
The main objective of this work was to monitor
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ranitidine HCl photodegradation by FTIR method.
Particularly, we studied ATR-FTIR, previously described
in a case of analysis ranitidine HCl determination(25-30).
Generally, researchers used this technique to study polymorphism of ranitidine HCl. Presented above results
(FTIR analysis) might suggest a change of polymorphic
Form 2 of ranitidine hydrochloride into Form 1. Specific
peak of Form 2-1045 cm-1(29) and its decreasing intensity on the FTIR spectra of tested samples during irradiation process could be responsible for polymorphism
change. On the other hand, another characteristic peak
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Figure 3. ATR-FTIR for ranitidine hydrochloride irradiated with the
exposure power of 280 W/m 2 up to 60 hours.
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Ranitidine hydrochloride irradiated for 60 hours
(P = 280 W/m²) showed considerable differences in either
the surface or investigated probes. Transmission technique illustrated spectral changes in ranitidine especially
in region of 3600-2400 cm-1. Spectrum did not lose its
character. Bands were well shaped but absorption values
increased (band at 3200 cm-1) by 50%. From equations
(1) and (2), we estimated the absorption changes after
exposure.
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Figure 4. Transmission FTIR for ranitidine hydrochloride irradiated
with the exposure power 700 W/m 2 up to 120 hours.
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Figure 5. ATR-FTIR for ranitidine hydrochloride irradiated with the
exposure power 700 W/m 2 up to 120 hours.
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of polymorphic Form 2-1620 cm-1(30) was stable. 13C
NMR analysis of the photodegradated sample proved
lack of changes in polymorphic Form 2. 13C NMR
and melting point of tested samples contradicted that
observed process is a polymorphic form change, but a
photodegradation process. The most important difference in polymorphic Forms occurred at about 100 ppm
- C(2) which was the carbon with nitro group (25). In this
region, the spectrum of Form 1 showed a singlet whereas
as opposed to a doublet in Form 2. In our case, spectrum
was always doubled either before or after irradiation of
samples. Another region to verify polymorphic forms
was at 24-25 ppm, where the spectrum was a singlet
in Form 1 and a doublet in Form 2. Note that we might
observe two doublets in each regions in determinated and
irradiated ranitidine hydrochloride. Extensive work was
being continuated in a subject of choosing other analytical methods (NMR or CE) suitable for photodegradation
detection of a solid-state ranitidine hydrochloride.
During irradiation procedure with the highest power
of weathering chamber P = 700 W/m 2 , we observed
increased temperature up to 45°C. We checked how this
increased temperature changed ranitidine hydrochloride
itself and also its spectrum using FTIR techniques. Discs
and an adhesive tapes containing ranitidine hydrochloride were tightly wrapped with aluminium foil (blank
probes, absorption A0) and were irradiated for 24 hours
with P = 700 W/m 2 (absorption A1). Spectra recorded for
blank probes undoubtedly showed no connection with
clear changes recorded for irradiated ranitidine spectra
influenced by temperature. The biggest differences were
observed between spectrum of blank probes and irradiated ones. Any changes in the spectra in the range above
2800 cm-1 were very likely caused by stretching N-H
from created secondary amines during irradiation and
also stretching aliphatic C-H groups.

CONCLUSIONS
The stability of drugs has been studied very
frequently in relation to heat, moisture, oxidation and
exposure to light (25,26,31). There are no evidences in literature about studying the first response of drug substance
exposure to light and its spectral consequences. Especially pharmaceuticals and drug substances need to
be constantly monitored. First contact with degradation factor may cause dramatic pharmacological effect
afterwards. Therefore, we recorded the plane of drug
substance (reflection technique) and total probe after
irradiation test. After a short time of exposure, some
changes did occur on the drug surface, but provoked no
visible results. Our purpose was to show the efficiency
and usability of ATR-FTIR for observing the earliest
changes occurring to drug substance, without isolation
and identification. The method involved disagreement
occurrence detection signal in substance spectrum after

absorbing some amount of energy. We chose a particularly sensitive method which could monitor changes
in surface structure. We demonstrated that this method
was a useful tool to observe the earliest changes on the
surface of a drug substance irradiated for a very short
time. When measuring the time needed to detect any
changes on the surface of ranitidine hydrochloride, FTIR
reflection technique was proven more efficient than the
transmission technique. During as few as 15 hours of
exposure to light (in the power of Atlas chamber 280
kW/m 2), we were able to observe structural changes in
ranitidine hydrochloride, but still only on the spectrum
recorded by reflection technique. Transmission technique
required 30-hour irradiation under the same conditions
for the disagreement signal to occur.
ATR-FTIR permits the analysis of all materials with
big absorption coefficient and requires neither specialist
equipment nor analytes. It is a very useful tool in continuous monitoring of a drug substance during production
process or storage. For recording any surface this method
enabled to observe the slightest and the first changes
occurring after irradiation – much earlier than using the
transmission technique.
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